AFFnet - a deep convolutional neural network for the detection of atypical femur fractures from anteriorposterior radiographs.

Antiresorptive Atypical femur fracture Osteoporosis Radiology Screening

Journal

Bone
ISSN: 1873-2763
Titre abrégé: Bone
Pays: United States
ID NLM: 8504048

Informations de publication

Date de publication:
27 Jul 2024
Historique:
received: 16 05 2024
revised: 14 07 2024
accepted: 26 07 2024
medline: 30 7 2024
pubmed: 30 7 2024
entrez: 29 7 2024
Statut: aheadofprint

Résumé

Despite well-defined criteria for radiographic diagnosis of atypical femur fractures (AFFs), missed and delayed diagnosis is common. An AFF diagnostic software could provide timely AFF detection to prevent progression of incomplete or development of contralateral AFFs. In this study, we investigated the ability for an artificial intelligence (AI)-based application, using deep learning models (DLMs), particularly convolutional neural networks (CNNs), to detect AFFs from femoral radiographs. A labelled Australian dataset of pre-operative complete AFF (cAFF), incomplete AFF (iAFF), typical femoral shaft fracture (TFF), and non-fractured femoral (NFF) X-ray images in anterior-posterior view were used for training (N = 213, 49, 394, 1359, respectively). An AFFnet model was developed using a pretrained (ImageNet dataset) ResNet-50 backbone, and a novel Box Attention Guide (BAG) module to guide the model's scanning patterns to enhance its learning. All images were used to train and internally test the model using a 5-fold cross validation approach, and further validated by an external dataset. External validation of the model's performance was conducted on a Sweden dataset comprising 733 TFF and 290 AFF images. Precision, sensitivity, specificity, F1-score and AUC were measured and compared between AFFnet and a global approach with ResNet-50. Excellent diagnostic performance was recorded in both models (all AUC >0.97), however AFFnet recorded lower number of prediction errors, and improved sensitivity, F1-score and precision compared to ResNet-50 in both internal and external testing. Sensitivity in the detection of iAFF was higher for AFFnet than ResNet-50 (82 % vs 56 %). In conclusion, AFFnet achieved excellent diagnostic performance on internal and external validation, which was superior to a pre-existing model. Accurate AI-based AFF diagnostic software has the potential to improve AFF diagnosis, reduce radiologist error, and allow urgent intervention, thus improving patient outcomes.

Identifiants

pubmed: 39074569
pii: S8756-3282(24)00204-7
doi: 10.1016/j.bone.2024.117215
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117215

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Peter R Ebeling reports financial support was provided by National Health & Medical Research Council. Peter R Ebeling reports a relationship with Amgen Inc., Sanofi, Alexion, Kyowa-Kirin that includes: funding grants. Senior author Peter R Ebeling is the Editor in Chief of Bone If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Hanh H Nguyen (HH)

Department of Medicine, School of Clinical Sciences, Monash University, Victoria, Australia; Department of Endocrinology, Monash Health, Victoria, Australia; Department of Endocrinology and Diabetes, Western Health, Victoria, Australia; Department of Medicine, The University of Melbourne, Victoria, Australia. Electronic address: hanh.nguyen@monash.edu.

Duy Tho Le (DT)

Department of Medicine, School of Clinical Sciences, Monash University, Victoria, Australia; Department of Information Technology, Monash University, Victoria, Australia.

Cat Shore-Lorenti (C)

Department of Medicine, School of Clinical Sciences, Monash University, Victoria, Australia.

Colin Chen (C)

Department of Medicine, School of Clinical Sciences, Monash University, Victoria, Australia.

Jorg Schilcher (J)

Department of Biomedical and Clinical Sciences, and the Wallenberg Centre for Molecular Medicine, Linköping University, Linköping, Sweden.

Anders Eklund (A)

Department of Biomedical Engineering, Linköping University, Linköping, Sweden.

Roger Zebaze (R)

Department of Medicine, School of Clinical Sciences, Monash University, Victoria, Australia.

Frances Milat (F)

Department of Medicine, School of Clinical Sciences, Monash University, Victoria, Australia; Department of Endocrinology, Monash Health, Victoria, Australia.

Shoshana Sztal-Mazer (S)

Department of Endocrinology and Diabetes, Alfred Health, Victoria, Australia; Department of Public Health and Preventative Medicine, Monash University, Melbourne, Australia.

Christian M Girgis (CM)

Department of Endocrinology, Royal North Shore Hospital, New South Wales, Australia; Department of Diabetes and Endocrinology, Westmead Hospital, New South Wales, Australia; Faculty of Medicine and Health, The University of Sydney, New South Wales, Australia.

Roderick Clifton-Bligh (R)

Department of Endocrinology, Royal North Shore Hospital, New South Wales, Australia; Department of Diabetes and Endocrinology, Westmead Hospital, New South Wales, Australia.

Jianfei Cai (J)

Department of Information Technology, Monash University, Victoria, Australia.

Peter R Ebeling (PR)

Department of Medicine, School of Clinical Sciences, Monash University, Victoria, Australia; Department of Endocrinology, Monash Health, Victoria, Australia.

Classifications MeSH